This Article Full Text Full Text (PDF) All Versions of this Article: 37/2/501    most recent 01.STR.0000198867.31134.acv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dingley, J. Articles by Thoresen, M. Search for Related Content PubMed PubMed Citation Articles by Dingley, J. Articles by Thoresen, M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Related Collections Other Treatment Neuroprotectors Other Stroke Treatment - Medical

(Stroke. 2006;37:501.)
© 2006 American Heart Association, Inc.

Original Contributions

Xenon Provides Short-Term Neuroprotection in Neonatal Rats When Administered After Hypoxia-Ischemia

From the University of Wales Swansea (J.D.), United Kingdom; St Michael’s Hospital (J.T., M.T.), University of Bristol, United Kingdom; and Leicester Royal Infirmary (H.P.), United Kingdom.

Correspondence to Marianne Thoresen, St. Michael’s Hospital-University of Bristol, Bristol, UK BS2 8EG. E-mail marianne.thoresen{at}bristol.ac.uk

Background and Purpose— Brain injury after hypoxic-ischemic insults evolves via an apoptotic/necrotic cascade. Glutamate over release and N-methyl-D-aspartate (NMDA) receptor over activation (excitotoxicity) are believed to trigger this process. Xenon is a nontoxic anesthetic gas that reduces neurotransmitter release and functionally antagonizes NMDA receptors. Administering xenon to hypoxic-ischemic newborns might be clinically effective if the neurotoxic processes continue evolving after delivery. We sought to determine whether xenon administration after the initial hypoxic-ischemic insult was neuroprotective.

Methods— Fifty 7-day-old rats received a 90-minute hypoxic insult after unilateral carotid ligation. They were then randomized to breathe 1 of 2 gas mixtures for 3 hours: 50% Xe/30% O₂/20% N₂ or 30% O₂/70% N₂.

Results— One week after hypoxic-ischemic survival, significant global protection was seen in the xenon group (80% less injury); cortex/white matter (88% versus 25%), hippocampus (62% versus 0%), basal ganglia (81% versus 25%), and thalamus (50% versus 0%; percentage of global damage score in nonxenon versus xenon groups, respectively).

Conclusions— Three hours of xenon administration commenced after hypoxia-ischemia in neonatal rats provides short-term neuroprotection. This finding suggests that treatment with xenon after perinatal asphyxia would also be neuroprotective. Because xenon does not cause other neurotoxic effects and has demonstrated minimal side effects in extensive anesthesia studies, it would make an ideal candidate for the treatment after human perinatal hypoxia-ischemia.

Key Words: anesthesia • neuroprotection • xenon • hypoxia • ischemia • newborn • asphyxia • rats • N-methyl-D-aspartate

This article has been cited by other articles:

				E. Chakkarapani, M. Thoresen, C. E. Hobbs, K. Aquilina, X. Liu, and J. Dingley A Closed-Circuit Neonatal Xenon Delivery System: A Technical and Practical Neuroprotection Feasibility Study in Newborn Pigs Anesth. Analg., August 1, 2009; 109(2): 451 - 460. [Abstract] [Full Text] [PDF]

				R. D. Sanders, D. Ma, P. Brooks, and M. Maze Balancing paediatric anaesthesia: preclinical insights into analgesia, hypnosis, neuroprotection, and neurotoxicity Br. J. Anaesth., November 1, 2008; 101(5): 597 - 609. [Abstract] [Full Text] [PDF]

				V. Degos, G. Loron, J. Mantz, and P. Gressens Neuroprotective Strategies for the Neonatal Brain Anesth. Analg., June 1, 2008; 106(6): 1670 - 1680. [Abstract] [Full Text] [PDF]

				H. N. David, B. Haelewyn, C. Rouillon, M. Lecoq, L. Chazalviel, G. Apiou, J.-J. Risso, M. Lemaire, and J. H. Abraini Neuroprotective effects of xenon: a therapeutic window of opportunity in rats subjected to transient cerebral ischemia FASEB J, April 1, 2008; 22(4): 1275 - 1286. [Abstract] [Full Text] [PDF]

				C. Hobbs, M. Thoresen, A. Tucker, K. Aquilina, E. Chakkarapani, and J. Dingley Xenon and Hypothermia Combine Additively, Offering Long-Term Functional and Histopathologic Neuroprotection After Neonatal Hypoxia/Ischemia Stroke, April 1, 2008; 39(4): 1307 - 1313. [Abstract] [Full Text] [PDF]

				J. Dingley, C. Hobbs, J. Ferguson, J. Stone, and M. Thoresen Xenon/Hypothermia Neuroprotection Regimes in Spontaneously Breathing Neonatal Rats After Hypoxic-Ischemic Insult: The Respiratory and Sedative Effects Anesth. Analg., March 1, 2008; 106(3): 916 - 923. [Abstract] [Full Text] [PDF]

				J. Dingley and R. S. Mason A Cryogenic Machine for Selective Recovery of Xenon from Breathing System Waste Gases Anesth. Analg., November 1, 2007; 105(5): 1312 - 1318. [Abstract] [Full Text] [PDF]

				S. J. Howell Carotid endarterectomy Br. J. Anaesth., July 1, 2007; 99(1): 119 - 131. [Abstract] [Full Text] [PDF]